Literature DB >> 9636338

Treatment of systemic lupus erythematosus: an update.

M Petri1.   

Abstract

Systemic lupus erythematosus predominantly affects women and is more common in blacks. Although survival rates have improved, over one half of patients with systemic lupus erythematosus have permanent damage in one or more organ systems. Arthritis and cutaneous manifestations are most common, but renal, hematologic and neurologic manifestations contribute largely to morbidity and mortality. Treatment approaches emphasize using a combination of drugs to minimize chronic exposure to corticosteroids.

Entities:  

Mesh:

Year:  1998        PMID: 9636338

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

1.  Connective tissue diseases: SLE-associated arthropathy: truly a benign entity?

Authors:  Grainne Murphy; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

2.  Kozhikode criteria for diagnosing systemic lupus erythematosus as a hematological disorder.

Authors:  N Arathi; P K Sasidharan; P Geetha
Journal:  J Blood Med       Date:  2016-03-08

Review 3.  Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.

Authors:  Timothy A Gottschalk; Evelyn Tsantikos; Margaret L Hibbs
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.